Global Antibiotic Resistance Market: Outlook, Current And Future Industry Landscape Analysis 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Antibiotic Resistance Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $15.47 billion In 2028 At A CAGR Of 6.3%.

The antibiotic resistance market size has grown strongly in recent years. It will grow from $11.43 billion in 2023 to $12.13 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to lack of new antibiotics, misuse and overuse of antimicrobials in humans, animals, and plants, highly contaminated waste effluents, low vaccination rates, lack of diagnostic tools.

The antibiotic resistance market size is expected to see strong growth in the next few years. It will grow to $15.47 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to incomplete treatment courses, globalization and travel, poor infection prevention and control, self-medication, cross-species transmission, high population density. Major trends in the forecast period include technological innovations in drug delivery, global collaboration for surveillance, expanding role of artificial intelligence, surge in novel therapies.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12131&type=smp

Antibiotic Resistance Market Major Segments
The antibiotic resistance market covered in this report is segmented -

1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus aureus, Staphylococcus pneumonia, Neisseria gonorrhoeae, Enterococcus Faecium, Escherichia coli, Klebsiella pneumonia, Shigella, Clostridium difficile, Other pathogens
3) By Disease Type: Urinary tract infection, Intra-abdominal infection, Blood stream infections, Clostridium difficile infections, Other Disease Types
4) By Mechanism of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty clinics, Other End-users

Key Driver - The Impact Of Rising Drug-Resistant Infections On The Antibiotic Resistance Market
The prevalence of drug-resistant infections is expected to propel the growth of the antibiotic-resistance market going forward. Drug-resistant infections are diseases caused by resistant bacteria, resulting in an infection that is far more difficult or impossible to cure. Antimicrobial resistance drugs help treat various drug-resistant infections with improved antibiotic treatment outcomes concerning both target and nontarget pathogens, dependent on the details of resistance mechanisms and microbiome community interaction structure. For instance, in November 2022, according to the European Centre for Disease Prevention and Control, a Sweden-based European Union agency for public health, around 35 000 persons in the EU/EEA die each year from antimicrobial-resistant diseases. Moreover, Klebsiella pneumoniae infections increased by 20% in 2021, and the number of Candida auris reported cases virtually doubled between 2020 and 2021. Therefore, the prevalence of drug resistance infection is driving the antibiotic resistance market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12131&type=smp

Prominent Trend - Product Innovations In The Antibiotic Resistance Market

Product innovations are the key trend gaining popularity in the antibiotic resistance market. Major companies operating in the antibiotic resistance market are focused on developing innovative products to strengthen their position in the market. For instance, in January 2023, Alkem Laboratories Limited, an India-based pharmaceutical company, introduced Zidavi, a novel antibiotic for multi-drug resistant (MDR) infections, to ensure availability, affordability, and accessibility while saving the lives of critically ill patients. Zidavi is a unique combination of ceftazidime and avibactam that can treat infections caused by multi-drug resistant (MDR) gram-negative pathogens. It is available for infusion in sterile powdered concentrate for reconstitution, comprising ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam in each single-dose vial. Also, it offers an effective alternative to treat hospital-acquired pneumonia (HAP) and severe intra-abdominal infections (IAIs) caused by meropenem and colistin.

Antibiotic Resistance Market Players
Major companies operating in the antibiotic resistance market report are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Merck and Co. Inc., Bristol-Myers Squibb, Sanofi S.A., Thermo Fisher Scientific Inc, AstraZeneca, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma, Daiichi Sankyo, Chugai Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories Inc, Eppendorf Corporation, Takara Bio Inc, Wockhardt Ltd., Paratek Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Theravance Biopharma Inc., Nabriva Therapeutics Plc, Seres Therapeutics Inc, Armata Pharmaceuticals Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/antibiotic-resistance-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the antibiotic resistance market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Antibiotic Resistance Market Report Structure
3. Antibiotic Resistance Market Trends And Strategies
4. Antibiotic Resistance Market - Macro Economic Scenario
5. Antibiotic Resistance Market Size And Growth
…..
27. Antibiotic Resistance Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.